Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin vs Placebo and Tamsulosin in Japanese BPH Patients
NCT00399464Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Sanofi. Started Nov 2006; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00399464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399464.